Acrivastine is a second-generation H1-receptor antagonist antihistamine clinically indicated for the management of allergic rhinitis, hay fever, and urticaria by effectively blocking histamine receptors.… Read more























Acrivastine is a second-generation H1-receptor antagonist antihistamine clinically indicated for the management of allergic rhinitis, hay fever, and urticaria by effectively blocking histamine receptors. Pharmaceutical laboratories require high-quality reference standards for this compound to ensure the precision and reliability of analytical testing during drug development and routine manufacturing. The available selection includes Acrivastine impurities, such as degradation products arising from oxidative, hydrolytic, or isomeric pathways, as well as critical synthetic analogs and process-related compounds. These materials are essential for robust impurity profiling and method validation, assisting researchers in maintaining strict product quality and regulatory compliance. Furthermore, stable isotope labelled compounds, including deuterium-labelled versions, serve as vital internal standards for accurate mass spectrometry-based quantification and complex quality control studies, supporting consistent adherence to established ICH guidelines for safety and therapeutic efficacy.